No Secrets. No Surprises. Just Smarter Pricing.

The PBM industry has spent years perfecting the art of fine print—layering in hidden fees, confusing rebate structures and pricing models that feel more like a gamble than a cost-saving strategy. Traditional PBMs thrive on this complexity, putting their profits ahead of plan sponsors and members. At WellDyne, we don’t play that game.

With our simple, transparent pricing model, there’s no mystery math or smoke and mirrors—just straightforward, pass-through pricing where you pay what we pay. Our focus is on true lowest net cost, not inflated list prices or rebate games.

Proof That Simplicity Pays Off

PBM savings shouldn’t be a guessing game. Here’s how smarter clinical intervention and a focus on net cost deliver real results:

When a prescriber submits a prior authorization for an excessively priced medication, we step in—not with action to inflate list price discounts, but with real action that drives cost savings. Less cost, same care. That’s the power of a smarter PBM.

A Model Built for Savings—Not Spreads

At WellDyne, we align our success with yours. Our model eliminates spread pricing, delivers 100% rebate pass-through and uses cost-plus pricing for mail and specialty drugs—ensuring plan sponsors get the best price, every time.

True savings go beyond price alone. That’s why we leverage strategic partnerships—like Mark Cuban Cost Plus Drugs—to access significantly lower prices when alternative sourcing making sense. Unlike traditional PBMs that prioritize rebate revenue, we prioritize net cost savings that actually reduce spend.

No Games, Just Results

At WellDyne, we keep it simple:

When interests are aligned, everyone wins. At WellDyne, we’ve always been focused on lowering net cost—and now, we’re making it even simpler. No hidden fees. No fine print. Just Clear™ value.